AIP successful in European contest for knowledge and technology transfer
From galaxy research to the fight against cancer – the research and innovation center innoFSPEC, part of the Leibniz Institute for Astrophysics Potsdam (AIP), receives funding by the European Commission for the development of pioneering technology for economy and society.
The rewarded idea is based on accomplishments in the transfer of high-technology from astronomy research to cancer diagnostics. The aim is an optical design study for the development of a prototype suitable for clinical studies. The innoFSPEC team under leadership of Prof. Dr. Martin Roth and a French industry partner, Winlight Systems, jointly and successfully entered the Attract contest. As part of the transfer idea “3D-CANCER-SPEC”, they will now develop a compact screening device, based on an original MUSE spectrograph, in a one-year funding phase. The concept will be publicized in a science journal and a presentation at the final Attract conference in September 2020 in Brussels. This support is expected to encourage funding of a medical device by funding bodies or industrial companies.
Basic research, as it is practiced at the AIP, facilitates excellence in the development of high-technology. Imaging spectroscopy with instruments like PMAS and MUSE and the analysis of huge amounts of data (big data) with artificial intelligence in eScience are some examples. Since its establishment in 2009, the research and innovation center innoFSPEC Potsdam engages in the utilization of high-technology developed during its research of optical technologies and photonics for economy and society. Among the center’s efforts is the transfer of imaging spectroscopy in astronomy to minimally invasive cancer diagnostics. This experiment, a cooperation with Charité-Universitätsmedizin Berlin, was successfully completed in 2018 with a publication in the renowned Journal of Biomedical Optics. Additionally, two further projects in the Leibniz research alliance Health Technologies address bladder cancer diagnostics and technological improvements for use in surgery. These projects in partnership with the Leibniz Association and industry partners have already led to one patent application.
One stated aim of the Pact for Research and Innovation is to strengthen the exchange of science with economy and society. Against this background, the biggest European research organizations such as the high energy laboratory CERN, the X-ray laser laboratory XFEL or the European South Observatory ESO have sponsored the project ATTRACT with a total of 17 million euros funded by the European Commission. All in all, the project rewards 170 exceptional transfer ideas in the area of detecting and imaging technologies. Among them are promising application innovations in microelectronics, information and communication or life sciences and medical technology.
Prof. Dr. Martin Matthias Roth, 0331-7499-313, email@example.com
Elmar Schmälzlin, Benito Moralejo, Ingo Gersonde, Johannes Schleusener, Maxim E. Darvin, Gisela Thiede, Martin M. Roth, “ Nonscanning large-area Raman imaging for ex vivo /in vivo skin cancer discrimination,” J. Biomed. Opt. 23 (10), 105001 (2018)